Skip to content
Insurance, Medical Health Aged Care

Flu shot concerns ahead of worrying flu season

April 11, 2025 3 mins read

Doctors are voicing concerns about the declining flu vaccination rate and say Australia faces the perfect storm this winter with an early start to what is expected to be a bad flu season.

 

Flu vaccinations among high-risk groups have been declining in recent years. Last year, only 61% of adults aged more than 65 were protected against the flu, compared to 70% in 2022. Among children under five, years, only a quarter were vaccinated for the flu last year, down from almost a third a few years ago.

 

Bupa Medical Director Dr Tony MacDermott encouraged Australians to book a flu shot between April and May to be covered in time for the expected peak in June and July.

 

There’s been a troubling decline in the number of people receiving the flu vaccine in recent years, and this puts both individual and public health in jeopardy,” Dr MacDermott said.

 

“As the COVID-19 pandemic slips further into people’s memories, we’re seeing an ongoing trend of vaccine complacency – and this is definitely not the year for it.

 

“Australians need to roll up their sleeves for the flu shot – it will potentially save their life, and those around them who are at risk. Getting the flu vaccine is one of the simplest and most effective things you can do to protect yourself, your family, and your community.”

 

Last year was the worst flu season in five years with more than 365,000 reported cases across Australia and more than 4,200 people admitted to hospital.

 

“This year is on track to be even worse, with twice as many flu cases already reported in Australia compared to the same time last year, and the flu season starting earlier than ever,” Dr MacDermott said.

 

One in three telehealth calls to doctors are currently relating to respiratory issues, according to data from Bupa’s digital health platform Blua, where eligible heath insurance customers have access to three telehealth bookings per year with zero out of pocket costs.

 

Dr MacDermott said modelling from the northern hemisphere flu season pointed to a very challenging season ahead. USA recorded the worst season since 2009 and many hospitals in the UK were swamped with flu cases.

 

“The severity of this flu season could result in a very significant number of preventable illnesses, hospitalisations, and even deaths. The flu has already infected tens of thousands of Australians each month in 2025, and that’s before we’ve reached peak flu season,” Dr MacDermott said.

 

“People are slowly losing the good habits learnt during the COVID-19 pandemic, such as getting vaccinated and staying home if you’re sick. These things are as important as ever.”

 

Infants aged six months to five years, adults aged 65 years and above, pregnant women, people with chronic health conditions, and the indigenous community are the most vulnerable groups to the flu. The flu vaccine is available for free for these at-risk groups.

 

Bupa expects to provide more than 52,000 flu vaccinations to organisations across Australia. They will be delivered onsite at workplaces and universities nationally and by our partnering pharmacies across more than 2,400 locations in Australia and New Zealand. 

 

ENDS

 

NOTE TO NEWS DESKS:

 

Interviews available with Bupa Clinical Director Dr Tony MacDermott

 

 

For more information, please contact:
Aleks Devic                                                    
Head of Media (Health Insurance) and Content, Bupa                             
Email:
[email protected]     

Mob: 0412 868 933                                                      

 

 

About Bupa Asia Pacific

Bupa is an international healthcare group which has been committed to a purpose of helping people live longer, healthier, happier lives and making a better world for more than 70 years.

Bupa Asia Pacific operates in Australia, New Zealand and Hong Kong, supporting about 7.3 million customers through a broad range of health and care services including health insurance, aged care, dental, medical, optical and hearing services.

Employing more than 22,000 people in the region, we believe that we can make a real difference to the lives of customers through our values, purpose and the way that we deliver personalised care.

Over the past 17+ years we have invested more than AUD$36 million in partnerships and programs focused on improving health of communities across Australia.



 

 

More from this category

  • Medical Health Aged Care, Research Development
  • 11/07/2025
  • 16:28
The Florey

Harnessing mRNA to prevent and slow Alzheimer’s disease

mRNA Victoria funds 2Floreyprojects to prevent and treat Alzheimer’s disease Key points mRNA Victoria has funded 2 Alzheimer’s disease research projects that could position Victoria as a leader in the development of mRNA-based therapies. Dr Abdel Belaidi will develop an mRNA-based system that crosses the blood-brain barrier and aims to slow or even halt disease progression. Dr Rebecca Nisbet will develop an mRNA vaccine that aims to prevent Alzheimer’s disease from developing. Florey researchers working at the cutting edge of dementia research have received funding from mRNA Victoria to develop treatments and a vaccine for Alzheimer’s disease. Since mRNA vaccines…

  • Medical Health Aged Care
  • 11/07/2025
  • 07:05
Royal Australian College of GPs

GPs urge Tasmanian families to get vaccinated against whooping cough and call for free shots to reduce barriers

The Royal Australian College of GPs (RACGP) is urging Tasmanian families to get vaccinated against pertussis, or ‘whooping cough’ and called on all parties and candidates running in the state election to commit to making the vaccination free for all patients. From 1 January 2024 to April 2025, 1238 whooping cough cases were notified in Tasmania, including 10 infants aged under six months. Most hospitalisations and deaths occur in this group, who are not old enough to have received all vaccine doses. More than 21,000 infections were recorded nationwide last year, compared to just 2450 in 2023, and the National…

  • Contains:
  • General News, Medical Health Aged Care
  • 11/07/2025
  • 07:00
La Trobe University

La Trobe researchers awarded $4.5 million in ARC Future Fellowships

LaTrobe University researchers have secured almost $4.5 million in Federal Government funding to further studies into areas such as immune cell development, Australian history and agriculture. Four researchers received an Australian Research Council (ARC) Future Fellowship 2025. The prestigious Future Fellowships support high quality research in areas of national and international benefit, including in national research priorities. Dr Lisa Mielke, from the School of Cancer Medicine, the La Trobe Institute of Molecular Science (LIMS) and the Olivia Newton-John Cancer Research Institute (ONJCRI), received $1.13 million to identify new molecules for future drug and vaccine development to improve gut health in…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.